CRGX CARGO Therapeutics, Inc Company Short-Term Debt

CARGO Therapeutics, Inc. - graphic logo of issuer CRGX

CARGO Therapeutics (CRGX) utilizes US CDMO capacities for the flexible production of drugs according to cGMP standards. The success of new blood treatment methods could grant the firm pricing power within its niches. This daily price chart reflects the asset's dynamics, where the metric stands at 0.00. The future implementation of automated bioreactors will eliminate human error during cell cultivation.

CRGX cargo-tx.com Short-Term Debt (02/21/2024 - 08/30/2025)

Analytical breakdowns and data insights for company CARGO Therapeutics, Inc (CRGX)

- current quotes and average value forecast:
Price Chart CARGO Therapeutics, Inc.|CRGX - Average Forecast Price
- market capitalization data:
Market Value CARGO Therapeutics, Inc.|CRGX - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share CARGO Therapeutics|CRGX - Total Stockholders' Equity|Market Capitalization to Book Value Ratio cargo-tx.com|CRGX - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio CARGO Therapeutics|CRGX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio CARGO Therapeutics|CRGX - Aggregate Debt Obligations|Debts to Book Capitalization CARGO Therapeutics, Inc.|CRGX - Company Long-Term Liabilities|Company Short-Term Debts CARGO Therapeutics|Quick Liquidity cargo-tx.com
- earnings and multiples data:
CRGX - Company Net Income
General company analysis:CARGO Therapeutics, Inc. (CRGX)
Flagship merchandise of cargo-tx.com

To protect capital amid market volatility, it is critical for investors to assess the liquidity of liabilities with maturities of up to one year. By analyzing the short-term debt trend, one can determine the extent to which the high burn rate for CAR-T therapy biomanufacturing and clinical risks exert pressure on the CARGO Therapeutics (CRGX) balance sheet, defining the asset's overall resilience to credit stress.

Competitor analysis

LEGN - Company Short-Term Debt|Short-Term Debt Sana Biotechnology Inc|Autolus Pharma (AUTL) - Company Short-Term Debt|ALLO (Allogene Corp) - Company Short-Term Debt|Company Short-Term Debt Cartesian Therapeutics|Short-Term Debt Cellectis Biotherapeutics CLLS|Company Short-Term Debts CRBU|Instil Bio Inc. (TIL) - Short-Term Indebtedness|Genenta Science - Company Current Liabilities|Century Tx (IPSC) - Short-Term Debt|JSPR: Company Current Liabilities|Company Short-Term Loans and Borrowings SNTI (Senti Biosciences, Inc.)|ADAP: Company Short-Term Debts|Company Current Liabilities CERo Therapeutics Holdings|TCRT (Alaunos Therapeutics Inc.) - Company Short-Term Debts|Short-Term Debt Achilles Tx ACHL|Company Short-Term Debt Poseida Therapeutics (PSTX)|Company Short-Term Debt TSVT (2seventybio.com)|Company Short-Term Debt Gracell Biotechnologies Inc. GRCL